Shanghai Lin Qingxuan Biotechnology Co., Ltd. was listed on the Hong Kong Stock Exchange today. According to the announcement, each share was priced at HK$7.777, and a total of 13.966,500 shares were issued, 50 shares per lot, with a net proceeds of approximately HK$997.1 million. Lam Ching Hsuan opened 9.3% higher in early trading. As of noon trading, it rose 14.37% to HK$88.65, with a turnover of $380.1 million and a market value of HK$12.42 billion. According to Insight Consulting data, in terms of retail sales in 2024, Lin Qingxuan is the number one high-end domestic skincare brand in China, the number one anti-wrinkle and firming skincare brand in China, and the only representative of domestic products among the top 15 high-end skincare brands in China.

Shanghai Lin Qingxuan Biotechnology Co., Ltd. was listed on the Hong Kong Stock Exchange today. According to the announcement, each share was priced at HK$7.777, and a total of 13.966,500 shares were issued, 50 shares per lot, with a net proceeds of approximately HK$997.1 million. Lam Ching Hsuan opened 9.3% higher in early trading. As of noon trading, it rose 14.37% to HK$88.65, with a turnover of $380.1 million and a market value of HK$12.42 billion. According to Insight Consulting data, in terms of retail sales in 2024, Lin Qingxuan is the number one high-end domestic skincare brand in China, the number one anti-wrinkle and firming skincare brand in China, and the only representative of domestic products among the top 15 high-end skincare brands in China.